<DOC>
	<DOCNO>NCT01743820</DOCNO>
	<brief_summary>The purpose study evaluate safety , efficacy , pharmacokinetics low single-dose primaquine gametocidal activity P.falciparum among adult glucose-6-phosphate dehydrogenase ( G6PD ) -normal malaria patient .</brief_summary>
	<brief_title>Phase2a Primaquine Dose Escalation Study</brief_title>
	<detailed_description />
	<mesh_term>Dihydroartemisinin</mesh_term>
	<mesh_term>Artemisinins</mesh_term>
	<mesh_term>Primaquine</mesh_term>
	<mesh_term>Piperaquine</mesh_term>
	<criteria>Male Age &gt; = 18 year &lt; 50 year Malaria blood thick film positive Presence gametocyte thick blood film Agrees admission study ward 26 hour post diagnosis available follow visit No allergy study drug Hemoglobin &gt; = 8 g/dl No evidence severe chronic disease Written , inform consent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>